Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank 144a Regulatory News (AXBA)

Share Price Information for Axis Bank 144a (AXBA)

Share Price is delayed by 15 minutes
Get Live Data
40.9145    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $25.45b
AXBA Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank 144a Share Chart

ESOP Grant

16 Jul 2025 09:38

RNS Number : 2977R
Axis Bank Limited
16 July 2025
Β 

AXIS/CO/CS/171/2025-26

Β 

July 16, 2025

Β 

National Stock Exchange of India Limited

Exchange Plaza, 5th Floor

Plot No. C/1, "G" Block

Bandra-Kurla Complex

Bandra (E), Mumbai - 400 051

Β 

NSE Symbol: AXISBANK

BSE Limited

1st Floor,

P. J. Towers,

Dalal Street

Fort, Mumbai - 400 001

Β 

BSE Scrip Code: 532215

Β 

Dear Sir/Madam,

Β 

REF.:

DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

SUB.:

GRANT OF STOCK OPTIONS/UNITS

Β 

This is to inform you that the Nomination and Remuneration Committee at its meeting held today i.e., July 16, 2025, has granted 1,37,575 stock options at an exercise price of Rs. 1,165.90/- per option under the Axis Bank Employees Stock Option Scheme 2000-01 to the eligible employees of the Bank.

Β 

Disclosures as required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed as Annexure A.

Β 

The meeting commenced at 10.30 am (IST) and concluded at 1:40 pm (IST).

Β 

This is for your information and records.

Β 

Yours faithfully,

Β 

For Axis Bank Limited

Β 

Β 

Sandeep Poddar

Company Secretary

CC:Β 

London Stock Exchange

Singapore Stock Exchange

Β 

Β 

Β 

Annexure A

Β 

Sr. No.

Particulars

Grant under Axis Bank Employees Stock Option Scheme 2000-01

(a)

Brief details of options/units granted

1,37,575 options.

(b)

Whether the scheme is in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Yes

(c)

Total number of shares covered by these options/units

1,37,575 equity shares of Rs. 2/- each of the Bank.

(d)

Pricing Formula

Granted at the latest available closing price prevailing on NSE being the Stock Exchange which recorded the highest trading volume in the equity shares of the Bank on July 15, 2025 i.e., being the previous trading day immediately preceding the date on which the grant of options was approved by the NRC.

(e)

Option Vested

The said options shall vest, as under:

- At the end of 1 year from the date of grant - 30% of granted options.

- At the end of 2 years from the date of grant - 30% of granted options.

- At the end of 3 years from the date of grant - 40% of granted options

(f)

Time within which option/units may be exercised

The said options can be exercised by the grantees, within a period of 5 years from the date of respective vesting.

Β 

Β http://www.rns-pdf.londonstockexchange.com/rns/2977R_1-2025-7-16.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCSFISAMEISEDW
Date   Source Headline
25th Jul 202212:33 pmRNSOutcome of Board meeting
20th Jul 20226:17 pmRNSIntimation of Earnings Call
12th Jul 20225:22 pmRNSRe-appointment of Chairman of the Bank
6th Jul 20228:27 amRNSBoard Meeting Intimation
5th Jul 20229:21 amRNSNOTICE OF 28TH ANNUAL GENERAL MEETING
24th Jun 20224:39 pmRNSRe-appointment of Deputy Managing Director
20th Jun 20222:39 pmRNSMOODY’S INVESTORS SERVICE RATING ACTION
16th Jun 20227:00 amRNSCredit Rating
1st Jun 20226:01 pmRNSCredit Rating
12th May 202210:11 amRNSCredit Rating Action
29th Apr 20221:48 pmRNSOutcome of Board Meeting - April 29, 2022
28th Apr 20222:57 pmRNSDisclosure of Related Party Transactions
28th Apr 202212:51 pmRNSOutcome of Board Meeting held on April 28, 2022
25th Apr 20221:44 pmRNSEarnings call intimation
11th Apr 20223:54 pmRNSPostal Ballot Results
8th Apr 20225:12 pmRNSRATING ACTION BY CARE RATINGS LIMITED
8th Apr 20221:02 pmRNSINTIMATION FOR BOARD MEETING
7th Apr 20221:26 pmRNSRATING ACTION BY CRISIL RATINGS LIMITED
30th Mar 20221:04 pmRNSPurchase of Citibank’s India Consumer Business
29th Mar 202210:34 amRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
28th Mar 20222:23 pmRNSAmendments to Fair Disclosure Code
22nd Mar 20222:38 pmRNSGrant of Stock Options
7th Mar 20223:19 pmRNSResults of Postal Ballot
4th Feb 20227:00 amRNSNotice of postal ballot
24th Jan 202212:36 pmRNSFinancial Results for quarter - December 31, 2021
18th Jan 20222:23 pmRNSEarnings Call - Update on Financial Results
10th Jan 20221:00 pmRNSAppointment of Company Secretary
10th Jan 202212:58 pmRNSRe-appointment of Deputy Managing Director
29th Dec 20217:00 amRNSRE-DESIGNATION
22nd Dec 202111:28 amRNSAllotment of Securities
21st Dec 20217:00 amRNSReclassification of Promoter
20th Dec 20217:00 amRNSUpdates
20th Dec 20217:00 amRNSCessation of Director
16th Dec 202112:13 pmRNSBoard Meeting to consider Financial Results
15th Dec 20211:58 pmRNSRating Action By Crisil Ratings Limited
15th Dec 20211:46 pmRNSRating action by ICRA Limited
14th Dec 202112:57 pmRNSAppointment of Director
9th Dec 20211:16 pmRNSApproval of Grant of Stock Options
30th Nov 20211:04 pmRNSReclassification of Promoters
30th Nov 20217:00 amRNSFitch Ratings Action
27th Oct 20211:25 pmRNSRe-designation - Deputy Managing Director
26th Oct 20212:17 pmRNSRelated Party Disclosure
26th Oct 20211:54 pmRNSUnaudited Financial Results - 30.09.2021
21st Oct 20217:33 amRNSEarnings call - Financial Results of the Bank
14th Oct 20213:29 pmRNSRe-appointment of Managing Director & CEO
12th Oct 202112:52 pmRNSReclassification of Promoter
29th Sep 20211:46 pmRNSChange in Director(s)
15th Sep 202112:34 pmRNSReclassification of Promoter
8th Sep 20212:17 pmRNSNotes Allotment Intimation
7th Sep 20214:12 pmRNSRating Action by CARE Ratings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.